This Company Is Using Generative AI To Design New Antibodies

  • 📰 Forbes
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 53%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

GenerativeAI: You’ve seen it with images like DALL-E, you’ve seen it with text like ChatGPT. Now you can see it with protein design as well.

AI-aided protein design requires massive amounts of data to train the models on. The field of antibody development has struggled to provide the high-quality biological data that is needed for good AI models to generate results: “Drug discovery has a biological data problem,” says CEO McClain. Absci has been collecting antibody data over the past decade, which has allowed the company to build its zero-shot generative AI method.

The happy marriage of synthetic biology and AI that has enabled creating new antibodies with the exact specifications you want was made possible thanks to another unlikely hero in this story. An important piece of the technology that positioned Absci for success was figuring out how to manufacture antibodies in, the model organism of synthetic biology. Traditionally, antibodies are made in mammalian cells, which are slower to grow and harder to manipulate.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 394. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Xerox is using robotics, AI, and AR to become more than just a printer companyCEO Steve Bandrowczak thinks the office printer is where the workplace revolution begins. They just need to copy what they've done before. Simply... They won't 👍
출처: verge - 🏆 94. / 67 더 많은 것을 읽으십시오 »

AI in finance: How ChatGPT, generative tools boost industry efficiencyAI in finance: How generative tools like ChatGPT can help with loan underwriting and even give personalized financial advice
출처: BusinessInsider - 🏆 729. / 51 더 많은 것을 읽으십시오 »